Combinatorial Anticancer Therapy Strategy Using a Novel GLUT Inhibitor with Chemotherapy and Target Drugs in vitro and in vivo
Abstract
DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.
Keywords:
Biological Sciences, Cancer, Nude Mice, Anticancer drugs, Cancer metabolism
Status
Undergraduate
Department
Biological Sciences
College
Honors Tutorial College
Campus
Athens
Faculty Mentor
Chen, Xiaozhuo
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Combinatorial Anticancer Therapy Strategy Using a Novel GLUT Inhibitor with Chemotherapy and Target Drugs in vitro and in vivo
DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.
Social Media Link
Twitter: @linzbach02
Instagram: lindsey.bachmann